发明名称 PDE1 INHIBITORS FOR OPHTHALMIC DISORDERS
摘要 PROBLEM TO BE SOLVED: To provide a therapeutic method that is useful to treat glaucoma or elevated intraocular pressure.SOLUTION: Phosphodiesterase 1 (PDE1) inhibitors expressed by formula III are administered, and the inhibitors are administered in combination with intraocular pressure-lowering agents, wherein Rand Rare each independently H or Calkyl; Rand Rare each independently H, Calkyl, aryl, heteroaryl, arylalkoxy, heteroarylalkoxy, heteroarylalkyl, or arylalkyl; or Ris H and Rand Rtogether form a di-, tri- or tetramethylene bridge; Ris a substituted heteroarylalkyl or heteroarylmethylene attached to N on a pyrazolo portion; Ris H, alkyl, aryl, heteroaryl, and the like; and n=0 or 1, when n=1, A is -C(RR)- .
申请公布号 JP2015212262(A) 申请公布日期 2015.11.26
申请号 JP20150102944 申请日期 2015.05.20
申请人 INTRA-CELLULAR THERAPIES INC 发明人 ROBERT DAVIS;ALLEN A FIENBERG
分类号 A61K31/519;A61K9/06;A61K9/08;A61K9/10;A61K31/527;A61K45/00;A61P27/02;A61P27/06;A61P43/00 主分类号 A61K31/519
代理机构 代理人
主权项
地址